Annual Accounts Receivable
$7.68 M
+$2.61 M+51.61%
31 December 2023
Summary:
Biodesix annual accounts receivable is currently $7.68 million, with the most recent change of +$2.61 million (+51.61%) on 31 December 2023. During the last 3 years, it has fallen by -$7.63 million (-49.82%). BDSX annual accounts receivable is now -49.82% below its all-time high of $15.30 million, reached on 31 December 2020.BDSX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$8.04 M
-$2.09 M-20.66%
30 September 2024
Summary:
Biodesix quarterly accounts receivable is currently $8.04 million, with the most recent change of -$2.09 million (-20.66%) on 30 September 2024. Over the past year, it has increased by +$2.26 million (+39.10%). BDSX quarterly accounts receivable is now -56.25% below its all-time high of $18.37 million, reached on 31 March 2021.BDSX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDSX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.6% | +39.1% |
| 3 y3 years | -49.8% | +188.7% |
| 5 y5 years | +305.9% | - |
BDSX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -49.8% | +110.0% | -20.7% | +188.7% |
| 5 y | 5 years | -49.8% | +305.9% | -56.3% | +188.7% |
| alltime | all time | -49.8% | +305.9% | -56.3% | +188.7% |
Biodesix Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.04 M(-20.7%) |
| June 2024 | - | $10.13 M(+2.4%) |
| Mar 2024 | - | $9.89 M(+28.8%) |
| Dec 2023 | $7.68 M(+51.6%) | $7.68 M(+32.9%) |
| Sept 2023 | - | $5.78 M(+40.3%) |
| June 2023 | - | $4.12 M(-16.0%) |
| Mar 2023 | - | $4.90 M(-3.2%) |
| Dec 2022 | $5.07 M | $5.07 M(+13.8%) |
| Sept 2022 | - | $4.45 M(-18.4%) |
| June 2022 | - | $5.45 M(+44.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.77 M(+3.2%) |
| Dec 2021 | $3.66 M(-76.1%) | $3.66 M(+31.3%) |
| Sept 2021 | - | $2.78 M(-47.3%) |
| June 2021 | - | $5.28 M(-71.2%) |
| Mar 2021 | - | $18.37 M(+20.0%) |
| Dec 2020 | $15.30 M(+189.2%) | $15.30 M(+183.6%) |
| Sept 2020 | - | $5.40 M(+83.2%) |
| June 2020 | - | $2.95 M(-44.3%) |
| Dec 2019 | $5.29 M(+179.7%) | $5.29 M |
| Dec 2018 | $1.89 M | - |
FAQ
- What is Biodesix annual accounts receivable?
- What is the all time high annual accounts receivable for Biodesix?
- What is Biodesix annual accounts receivable year-on-year change?
- What is Biodesix quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Biodesix?
- What is Biodesix quarterly accounts receivable year-on-year change?
What is Biodesix annual accounts receivable?
The current annual accounts receivable of BDSX is $7.68 M
What is the all time high annual accounts receivable for Biodesix?
Biodesix all-time high annual accounts receivable is $15.30 M
What is Biodesix annual accounts receivable year-on-year change?
Over the past year, BDSX annual accounts receivable has changed by +$2.61 M (+51.61%)
What is Biodesix quarterly accounts receivable?
The current quarterly accounts receivable of BDSX is $8.04 M
What is the all time high quarterly accounts receivable for Biodesix?
Biodesix all-time high quarterly accounts receivable is $18.37 M
What is Biodesix quarterly accounts receivable year-on-year change?
Over the past year, BDSX quarterly accounts receivable has changed by +$2.26 M (+39.10%)